E
Lyell Immunopharma, Inc. LYEL
$0.5854 -$0.0209-3.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -67.65% 161.54%
Total Other Revenue -- --
Total Revenue -67.65% 161.54%
Cost of Revenue -- --
Gross Profit -67.65% 161.54%
SG&A Expenses 23.39% -3.97%
Depreciation & Amortization -- --
Other Operating Expenses -96.85% 25.20%
Total Operating Expenses 22.19% -1.94%
Operating Income -22.25% 1.99%
Income Before Tax -330.51% 2.68%
Income Tax Expenses -- --
Earnings from Continuing Operations -330.51% 2.68%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -330.51% 2.68%
EBIT -22.25% 1.99%
EBITDA -23.77% 1.72%
EPS Basic -294.25% 3.07%
Normalized Basic EPS -15.85% 0.18%
EPS Diluted -294.25% 3.07%
Normalized Diluted EPS -15.85% 0.18%
Average Basic Shares Outstanding 9.22% 0.36%
Average Diluted Shares Outstanding 9.22% 0.36%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings